BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Baxter
Johnson and Johnson
Federal Trade Commission
Covington
Medtronic
McKinsey
US Department of Justice
Moodys

Generated: January 19, 2018

DrugPatentWatch Database Preview

Decitabine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for decitabine and what is the scope of decitabine freedom to operate?

Decitabine
is the generic ingredient in two branded drugs marketed by Otsuka Pharm Co Ltd, Accord Hlthcare, Chemi Spa, Dr Reddys Labs Ltd, Pharmascience Inc, Sandoz Inc, and Sun Pharma Global, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for decitabine. Seven suppliers are listed for this compound.
Pharmacology for decitabine

US Patents and Regulatory Information for decitabine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd DECITABINE decitabine INJECTABLE;INTRAVENOUS 203131-001 Jul 11, 2013 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Accord Hlthcare DECITABINE decitabine INJECTABLE;INTRAVENOUS 203475-001 Feb 27, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc DECITABINE decitabine INJECTABLE;INTRAVENOUS 202969-001 Aug 28, 2014 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmascience Inc DECITABINE decitabine INJECTABLE;INTRAVENOUS 204607-001 May 31, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Otsuka Pharm Co Ltd DACOGEN decitabine INJECTABLE;INTRAVENOUS 021790-001 May 2, 2006 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Chemi Spa DECITABINE decitabine INJECTABLE;INTRAVENOUS 206033-001 Sep 22, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global DECITABINE decitabine POWDER;INTRAVENOUS 205582-001 Jan 28, 2014 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Chinese Patent Office
Harvard Business School
UBS
Cerilliant
Julphar
QuintilesIMS
Cipla
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot